Two statisticians holding a homemade pecan pie and a bowl of cornbread.
Yesterday our statisticians had a team meeting where they discussed some controversial topics in statistics. To celebrate Thanksgiving some of our statisticians from the USA brought in pecan pie and cornbread to share in the meeting.
28.11.2025 13:54 — 👍 5 🔁 0 💬 0 📌 0
The event aims to encourage female students to continue studying STEM subjects at college and university. Holly spoke about her career to date and what being a #TrialStatistician involves.
17.11.2025 09:48 — 👍 2 🔁 1 💬 0 📌 0
Holly Tovey stood talking to an audience with 3 other panel members behind her.
Last week, principal statistician @hollytovey.bsky.social attended Reigate College to speak at their #WomenInSTEM applicants event.
17.11.2025 09:48 — 👍 9 🔁 1 💬 1 📌 0
The successful candidate will be responsible for:
• Day to day management of the trial(s);
• Liaising with stakeholders and participating centres to ensure successful recruitment and delivery;
• Co-ordination of data management and biological sample collection activities.
31.10.2025 11:39 — 👍 1 🔁 0 💬 0 📌 0
Our Sustainability Project Manager, Jessica Griffiths, attended the Conference on Research Outcomes in Environmental Sustainability jointly run by the Medical Research Council @nihr.bsky.social, and Greener NHS yesterday to present our poster on Greener Trials. #GreenSky 🧪
24.10.2025 14:56 — 👍 6 🔁 0 💬 0 📌 0
If you are @myesmo.bsky.social Congress this weekend, don't miss Prof @christinayap.bsky.social's presentation on Common mistakes in biostatistics: a crash course, in the Young Oncologists session tomorrow.
17.10.2025 11:01 — 👍 3 🔁 0 💬 0 📌 0
BIG Pink October Webinar 2025
BIG Pink October Webinar 2025 - Breast International Group
Our Assistant Operations Director, Dr @lisa-fox.bsky.social, is presenting the Greener Trials project at next week's @bigxresearch.bsky.social Pink October Webinar 2025.
Find out more and register to attend here:
bigagainstbreastcancer.org/events/big-p...
#BreastCancer #GreenSky
17.10.2025 10:50 — 👍 6 🔁 1 💬 0 📌 1
Sustainability
Find out more about our sustainability work here:
www.icr.ac.uk/research-and...
16.10.2025 10:00 — 👍 0 🔁 0 💬 0 📌 0
Application Developer in Sutton | The Institute of Cancer Research
View details and apply for this Application Developer vacancy in Sutton.
Salary : £39,805 - £49,023 - Commencement on the salary range is subject to comparable skills and experience.
...
Join our team!
We are recruiting an Application Developer for our Greener Trials project. The successful applicant will develop an online Greener Trials Toolkit to help researchers assess and mitigate the environmental impact of their trials.
#Greensky #ITjobs 🧪
jobs.icr.ac.uk/vacancies/13...
16.10.2025 09:59 — 👍 2 🔁 0 💬 1 📌 0
I’ve been speaking with yr11-13s about careers in cancer research this evening. These events always remind me of how lucky I am to work in a multidisciplinary research setting - applying statistics to things that matter to patients. @icr-ctsu.bsky.social @icr.ac.uk
14.10.2025 20:32 — 👍 3 🔁 1 💬 0 📌 0
One of our trial managers presented on our experience of a recent routine MHRA inspection. A clinical trials programme manager presented as part of the real world experiences of eTMF systems session. And finally our sustainability project manager presented about greener trials.
10.10.2025 14:28 — 👍 3 🔁 0 💬 0 📌 0
Earlier this week some of our staff attended the UK CRC Trial Management Operational Meeting where they shared some recent experiences.
10.10.2025 14:28 — 👍 1 🔁 0 💬 1 📌 0
INTERACT infographic:
Cancer trials check that new treatments are safe and work as intended. They should be accessible to all different types of people who will have the treatment. INTERACT aims to find out:
Are there any differences between people who took part in research into cancer treatments in the UK and those who didn’t?
Who is less likely to take part in cancer research in hospitals today? And is this because they don’t know about the research or because they choose not to take part?
Can we build strong relationships with people from different backgrounds to understand how to support wider participation in cancer research?
INTERACT is exploring who took part in recent cancer clinical trials to find out whether anyone was less likely to be included.
Results will help us develop dedicated support for any groups who have been left out in the past. Find out more about the project here: www.icr.ac.uk/interact
09.10.2025 09:55 — 👍 2 🔁 0 💬 0 📌 0
Dr Akala holding a microphone and standing at a podium. The title slide of presentation is shown in the background: INTERACT-P: An audit of cancer trial participation demographics - challenges and early progress
We were at the NIHR Biomedical Research Centre and Clinical Research Facility Research inclusion conference earlier this week, where Dr Yemi Akala presented our INTERACT Project.
09.10.2025 09:47 — 👍 4 🔁 0 💬 1 📌 0
Results showed that, for patients with head and neck cancer, there was no evidence of a difference in rates of key toxicities between standard intensity-modulated radiotherapy (IMRT) and proton beam therapy (PBT).
07.10.2025 10:15 — 👍 3 🔁 1 💬 0 📌 0
Results from the TORPEdO trial were presented at the American Society of Radiation Oncology (ASTRO) Annual Meeting last week.
07.10.2025 10:15 — 👍 2 🔁 1 💬 1 📌 0
Ragu Ratnakumaran will be presenting 'Two-year toxicity outcomes from PACE-C: Stereotactic Body Radiotherapy (SBRT) versus moderate hypofractionated #radiotherapy (MHRT)' on Tuesday 20th September at 02:40pm PT in Room 22/23. #ProstateCancer
26.09.2025 16:45 — 👍 2 🔁 0 💬 0 📌 0
Dr David Thomson will be presenting 'Primary Results for the Phase III Trial of Toxicity Reduction using Proton Beam Therapy for #OropharyngealCancer (TORPEdO; CRUK/18/010)' in the plenary session on Monday 29th September at 1:48pm PT in the San Francisco Ballroom.
26.09.2025 16:44 — 👍 1 🔁 0 💬 1 📌 0
We are excited to be attending the 67th annual #ASTRO meeting in San Francisco where the TORPEdO primary results and the two-year toxicity outcomes from PACE-C will be presented. 🧪
26.09.2025 16:44 — 👍 2 🔁 0 💬 1 📌 0
Today is #WorldCancerResearchDay 🌎 👩🔬 👨🔬
We're incredibly proud to have a community that is driving innovation, making ground-breaking discoveries, and transforming the future of cancer research.
Thank you to everyone who is helping us move closer to defeating cancer.
24.09.2025 11:03 — 👍 1 🔁 2 💬 0 📌 0
The results confirmed the impact of breast cancer diagnoses on people’s lives, even in a high-income country with a national health service.
The research was conducted as part of Szeyi Ng's PhD project, overseen by Prof Charlotte Coles, Prof Judith Bliss and Lucy Kilburn.
05.09.2025 11:56 — 👍 0 🔁 0 💬 0 📌 0
470 people with primary breast cancer and 136 with metastatic breast cancer responded. 27% PBC and 35% MBC respondents had experienced financial problems and 47% MBC respondents reported trouble fulfilling caring responsibilities at the time of survey completion.
05.09.2025 11:56 — 👍 0 🔁 0 💬 1 📌 0
Recruitment to cancer #ClinicalTrials is often highly selective, and some people face barriers to participation.
To prevent these issues from limiting our progress against the disease, we're working to bridge the gap between clinical trials and real-world practice ⬇️
www.icr.ac.uk/research-and...
14.08.2025 13:36 — 👍 2 🔁 2 💬 0 📌 0
COBRA infographic: BCG has been used to treat early bladder cancer for over 40 years and is put inside the bladder to stimulate the immune system to attack cancer cells. BCG can cause side effects which stop people from having a full course of treatment. Gem-Doce, two chemotherapy drugs, has been used in the bladder to treat early bladder cancer in the USA. The COBRA study will include 520 people from the UK with early bladder cancer. It will investigate whether Gem-Doce works as well as BCG to prevent cancer returning, with fewer side effects.
COBRA is investigating an alternative treatment for early bladder cancer and is currently in setup. Find out more information about the trial here:
www.icr.ac.uk/research-and...
05.09.2025 09:39 — 👍 1 🔁 0 💬 0 📌 0
Professor Clinical Oncology, Manchester UK. Combined rad/med onc aka ClinOnc. Views my own
Radiotherapy, oncology, clinical trials methodology, evidence synthesis, HTA, outdoors, beaches, dogs.
Research Associate at HRB-TMRN
Views my own.
PhD candidate and Clinical Trial Manager at the Clinical Trials and Statistics Unit at the Institute of Cancer Research.
Interested in clinical trial methodology, patient and public involvement, and science communication.
All views my own.
Senior Research Fellow in Inclusive Research. Co-lead @trialforge.bsky.social Inclusive Research Centre; Co-lead https://deependgps.bristol.ac.uk/. Research interests: #inclusiveresearch, #healthequity, #clinicaltrials, #communityengagement
The International PPI Network connects individuals working in, involved with and interested in patient and public involvement across the globe. Join us at https://intppinetwork.wixsite.com/ippin
Here we share news and views from @ProstateCancerUK for our growing professional community who have an interest in prostate disease 🧑🔬⤵️
We're here to make sure that by 2050 everyone diagnosed with breast cancer lives, and is supported to live well.
The UK charity dedicated to improving the lives of people with bladder cancer.
Principal Statistician at ICR-CTSU
Statistician. Interests: clinical trials methods, psychology, MSK medicine, rheumatology, oncology, chronic pain, adaptive trials, outcomes, digital health/wearables, Open Research, Stata, R, and code ligatures.
https://orcid.org/0000-0002-1574-9933
CTU Director and Statistician
Offial Bluesky account of the National Radiotherapy Trials Quality Assurance (RTTQA) Group in the UK. Views own. Reposts are not endorsements.
The Lancet Oncology is the global leader in clinical oncology publishing peer-reviewed research and reviews, comment, news, and Commissions. IF=35·9.
🌐 https://www.thelancet.com/journals/lanonc/home
Healing through innovation, competence and partnership. #BreastCancer #CancerResearch #ClinicalTrials
https://www.gbg.de/
Professor of Primary Care Research and Head of the Centre for Academic Primary Care (@capcbristol.bsky.social), Bristol. Academic mentor and certified coach. Integrates qualitative studies within RCTs to improve their design, delivery and intepretation.
Professor of Applied Linguistics & TESOL at University College London | Departmental Co-head of Research & Inclusion Co-lead | Co-Editor of the journal, Language Testing | Additional interests in health communication & trials methodology
Director of Edinburgh Clinical Trials Unit | NIHR Senior Investigator | innovative trials methods | robust development & evaluation of complex interventions | data science for trials
👨🏻⚕️Striving to make health research and clinical trials more inclusive
https://tinyurl.com/Lbresearchlinkedin
✍️Elsewhere, writer also interviewing writers
https://bsky.app/profile/liamhbishopwriting.bsky.social
Senior Lecturer in Trials Methodology and Deputy Research Director EDI Bristol Medical School. Trying to make research as inclusive as it can be. Working Mum who loves the outdoors 🌲🏊♀️🏃♀️👟🫶
Clinical trials quality assurance manager, sometime methodologist, Leeds CTRU. Views my own. Motivated to make trials ethical, efficient & a good experience for participants. Brummie of sorts (#UTV), based in Sheffield